Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00000311 · ClinicalTrials.gov registry record · Phase 3

Combining Behavioral Treatment With Agonist Maintenance - 1

A Phase 3 study, sponsored by Yale University.

Completed
Registry status
Phase 3
Development phase
168
Enrollment target

NCT00000311: Completed Phase 3 study, sponsored by Yale University.

NCT00000311 is a Phase 3 study that has completed, run by Yale University. The registered enrollment target is 168 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (78% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00000311, a Phase 3 study, has completed, sponsored by Yale University.

COMPLETED
Registry status
Phase 3
Development phase
168 participants
Enrollment target

Study Summary

The purpose of this study is to evaluate whether the community reinforcement approach (CRA) plus contingency management (CM) is more effective overall than CRA only in reducing illicit opioid and cocaine use during agonist maintenance treatment and at 3 and 6 month follow-up after completion of study protocol, and to compare the efficacy of maintenance on buprenorphine to methadone when maintenance is combined with CRA only or CRA plus CM.

Interventions

  • DRUG Buprenorphine
  • DRUG methadone

Trial Details

FieldValue
Enrollment Target 168 participants
Start Date 1995-02
Est. Completion 1999-02
Phase Phase 3
Yale University

1,492 total trials

What the finished NCT00000311 record still lists

NCT00000311 is an interventional study that assigns participants to a tested intervention. The registered 168 participants enrollment target is mid-sized for trials with a published cap, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (78% lower).

The record links to 0 conditions, and to 2 interventions - of which Buprenorphine is the first listed.

NCT00000311 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00000311 about?

NCT00000311 is a clinical study titled "Combining Behavioral Treatment With Agonist Maintenance - 1". The purpose of this study is to evaluate whether the community reinforcement approach (CRA) plus contingency management (CM) is more effective overall than CRA only in reducing illicit opioid and cocaine use during agonist maintenance treatment and at 3 and 6 month follow-up after completion of stud...

What is the current status of trial NCT00000311?

This trial is currently completed. It is a Phase 3 study. The enrollment target is 168 participants. The study started on 1995-02. Estimated completion is 1999-02.

What interventions are being tested in trial NCT00000311?

The interventions under investigation include: Buprenorphine (DRUG), methadone (DRUG).

Who is sponsoring clinical trial NCT00000311?

This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT00000311's enrollment target sits among peer trials

168 1459th of 2000 higher than 538 of 2,000 other Phase 3 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02118922 · 168 participants

    A Study to Test the Diagnostic Potential of Brillouin Microscopy for Corneal Ectasia

  • NCT03536897 · 168 participants

    IORT Following Breast Conserving Surgery for Early Stage Breast Cancer Registry

  • NCT04078230 · 168 participants · NA

    Regional or Extend LymphAdenectomy During Resection of Intrahepatic Cholangiocarcinoma

  • NCT04159168 · 168 participants · NA

    Facial Affect Sensitivity Training for Young Children With Callous-unemotional Traits

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00000311, the US trial registry maintained by the National Library of Medicine. NCT00000311 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.